Status:
UNKNOWN
Telangiectatic Palmoplantar Keratoderma in Systemic and Subacute Lupus Erythematosus
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Systemic Lupus Erythematosus
Lichen Planus
Eligibility:
All Genders
18+ years
Brief Summary
Palmoplantar keratoderma (PPK) associated to livid telangiectatic erythema during systemic lupus erythematosus (SLE) and subacute cutaneous lupus erythematosus (SCLE) is a rare phenomenon seldom repor...
Detailed Description
Context: Palmoplantar keratoderma (PPK) associated to livid telangiectatic erythema during systemic lupus erythematosus (SLE) is a rare phenomenon seldom reported in literature. To our knowledge no ca...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- \> 18 years old
- suffering from SLE or SCLE according to 2019 ACR/EULAR criteria
- With palmar and or plantar keratoderma with livid telangiectatic erythema
- Exclusion criteria:
- \< 18 years old
- suffering from lupus lesions without SLE or SCLE criteria
- without palmar and or plantar keratoderma with livid telangiectatic erythema
Exclusion
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2020
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT04356014
Start Date
April 1 2020
End Date
December 30 2020
Last Update
April 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uh Montpellier
Montpellier, France, 34295